Zobrazeno 1 - 10
of 96
pro vyhledávání: '"Clifton L. Gooch"'
Autor:
Chase Kingsbury, Shaila Ghanekar, Yangxin Huang, Yayi Zhao, Tetsuo Ashizawa, Sheng-Han Kuo, Clifton L. Gooch, Theresa A. Zesiewicz
Publikováno v:
Contemporary Clinical Neuroscience ISBN: 9783031243448
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::9ecfba616e0a6c92f8172176aa29678b
https://doi.org/10.1007/978-3-031-24345-5_29
https://doi.org/10.1007/978-3-031-24345-5_29
Autor:
Theresa A. Zesiewicz, Nicolas Dohse, Clifton L. Gooch, Yarema B. Bezchlibynk, Shaila Ghanekar
Publikováno v:
Tremors ISBN: 0197529658
Despite millions of people being affected by tremor worldwide, information regarding tremor patients’ ethnicity and racial diversity is limited. We examined diversity and inclusivity in two diseases, essential tremor (ET) and Parkinson disease (PD)
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::61a7d988cdf9d9dfc8f7232579a8118a
https://doi.org/10.1093/med/9780197529652.003.0017
https://doi.org/10.1093/med/9780197529652.003.0017
Autor:
Tuan Vu, Niraja Suresh, Brittany Harvey, Allison Schleutker, Natalie Anthony, Samuel Dang, Jerrica R. Farias, Clifton L. Gooch, Raul Alsina
Publikováno v:
Muscle & Nerve. 64:351-357
INTRODUCTION/AIMS Intravenous immunoglobulin (IVIg) is a common therapy for patients with chronic inflammatory demyelinating polyneuropathy (CIDP). IVIg may cause systemic adverse events (AEs); therefore, infusion of subcutaneous immunoglobulin (SCIg
Publikováno v:
Case Reports in Neurology
Case Reports in Neurology, Vol 13, Iss 1, Pp 65-72 (2021)
Case Reports in Neurology, Vol 13, Iss 1, Pp 65-72 (2021)
The recombinant humanized monoclonal antibody eculizumab has been shown to be effective and well tolerated in patients with anti-acetylcholine receptor antibody-positive, treatment-refractory generalized myasthenia gravis (gMG). Myasthenia gravis (MG
Autor:
Ikjae Lee, Mazen M. Dimachkie, Andrea M. Corse, Carlayne E. Jackson, Hongyan Xu, Jerry M. Belsh, J. Americo Fernandes, Mamatha Pasnoor, Tuan Vu, Eroboghene E. Ubogu, James F. Howard, George A. Small, Robert P. Lisak, R. Bhavaraju Sanka, Vanessa Baute, James Caress, Lin Mei, Stephen N. Scelsa, Brandy Quarles, Zachary Simmons, Richard Nowak, Zheng Yu, Richard J. Barohn, Jin-Xiu Pan, Clifton L. Gooch, Michael H. Rivner, Andrea Swenson
Publikováno v:
Muscle & Nerve
Introduction Our aim in this study was to identify the prevalence and clinical characteristics of LRP4/agrin‐antibody–positive double‐seronegative myasthenia gravis (DNMG). Methods DNMG patients at 16 sites in the United States were tested for
Autor:
Chuanhai Cao, Yazan Suradi, Tuan Vu, Xiaoyang Lin, Kristyn Pocock, Samuel Dang, Brittany Harvey, Niraja Suresh, Kyle Sutherland, Clifton L. Gooch
Publikováno v:
Journal of Clinical Neuromuscular Disease. 21:127-134
Objective We evaluated the safety and tolerability of higher-dose granulocyte colony-stimulating factor (G-CSF) in patients with amyotrophic lateral sclerosis. In addition, rates of disease progression and serum G-CSF levels and other immunological a
Autor:
Emily K. Plowman, Terrie Vasilopoulos, Clifton L. Gooch, Raele Robison, Lauren Tabor-Gray, K. Michelle Rosado, Jennifer L. Chapin, Tuan Vu, Joy Gaziano
Publikováno v:
Muscle & Nerve. 59:40-46
INTRODUCTION The purpose of this study was to determine the impact of an in-home expiratory muscle strength training (EMST) program on pulmonary, swallow, and cough function in individuals with amyotrophic lateral sclerosis (ALS). METHODS EMST was te
Autor:
Michael Benatar, Terry Heiman-Patterson, Merit Cudkowicz, Stephen Apple, Stanley H. Appel, James D. Berry, Jeremy M. Shefner, Jurjen Westra, Robert Bowser, Sally K. Nelson, Angela Genge, Clifton L. Gooch, Benjamin Rix Brooks, Wendy Agnese, Charlotte Merrill
Publikováno v:
Neurology: Clinical Practice
article-version (Version of Record) 3
article-version (Version of Record) 3
ObjectivesTo identify putative biomarkers that may serve as quantifiable, biological, nonclinical measures of the pharmacodynamic effect of edaravone in amyotrophic lateral sclerosis (ALS) and to report real-world treatment outcomes.MethodsThis is a
Autor:
Seok Hun Kim, Kelly L. Sullivan, Jason L. Salemi, Israt Jahan, Theresa A. Zesiewicz, Lynn Wecker, Jeannie Stephenson, Clifton L. Gooch, Yangxin Huang, Jessica D. Shaw
Publikováno v:
Gait & Posture. 55:25-30
Introduction Friedreich’s Ataxia (FA) is a devastating, progressive, neurodegenerative disease. Objective measures that detect changes in neurological function in FA patients are needed to facilitate therapeutic clinical trials. The purpose of this
Publikováno v:
Annals of Neurology. 81:479-484